News Image

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit

Provided By GlobeNewswire

Last update: Oct 31, 2024

Poster presentation at SITC to highlight extended follow-up data from AMPLIFY-7P Phase 1 study

Oral presentation at SU2C Innovation Summit to highlight data from AMPLIFY-7P and AMPLIFY-201 Phase 1 studies

Read more at globenewswire.com

ELICIO THERAPEUTICS INC

NASDAQ:ELTX (8/12/2025, 5:46:01 PM)

After market: 9.86 +0.46 (+4.89%)

9.4

+0.75 (+8.67%)



Find more stocks in the Stock Screener

Follow ChartMill for more